Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Luis Ruilope

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Concepts & Ideas

Anatomy

Physiology

Glomerular Filtration Rate

Procedures

Combination Drug Therapy

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Segura Julian; Ruilope Luis M
Treatment of prehypertension in diabetes and metabolic syndrome: what are the pros?
Ruilope Luis M; Segura Julian; Fujita Toshiro; Ritz Eberhard
Renal and cardiovascular events: do they deserve the same consideration in clinical trials?
Segura Julian; Ruilope Luis M
Should diuretics always be included as initial antihypertensive management in early-stage CKD?

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Luis Ruilope (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Segura Julian; Ruilope Luis M
Treatment of prehypertension in diabetes and metabolic syndrome: what are the pros?
Diabetes care 2009;32 Suppl 2():S284-9.
2009: Ruilope Luis M; Segura Julian; Fujita Toshiro; Ritz Eberhard
Renal and cardiovascular events: do they deserve the same consideration in clinical trials?
Journal of hypertension 2009;27(9):1743-5.
2009: Segura Julian; Ruilope Luis M
Should diuretics always be included as initial antihypertensive management in early-stage CKD?
Current opinion in nephrology and hypertension 2009;18(5):392-6.
2009: Ruilope Luis M
Simultaneous cardiac and renal damage in a hypertensive population.
Journal of clinical hypertension (Greenwich, Conn.) 2009;11(6):301-2.
2009: de la Sierra Alejandro; Zamorano Jose Luis; Ruilope Luis M
Application of hypertension guidelines in clinical practice: implementation of the 2007 ESH/ESC European practice Guidelines in Spain.
Journal of hypertension 2009;27 Suppl 3():S27-32.
2009: Waeber Bernard; de la Sierra Alejandro; Ruilope Luis M
Target organ damage: how to detect it and how to treat it?
Journal of hypertension 2009;27 Suppl 3():S13-8.
2009: Ruilope Luis M
Arterial hypertension greatly contributes to the development and evolution of cardiovascular and renal diseases. Editorial.
Journal of hypertension 2009;27 Suppl 3():S1.
2009: Ruilope Luis M; Segura Julian
Kidney protection: a key target in the management of patients with diabetes.
Journal of hypertension 2009;27 Suppl 1():S15-8.
2009: Zanchetti Alberto; Mancia Giuseppe; Black Henry R; Oparil Suzanne; Waeber Bernard; Schmieder Roland E; Bakris George L; Messerli Franz H; Kjeldsen Sverre E; Ruilope Luis M
Facts and fallacies of blood pressure control in recent trials: implications in the management of patients with hypertension.
Journal of hypertension 2009;27(4):673-9.
2009: de la Sierra Alejandro; Redon Josep; Banegas José R; Segura Julián; Parati Gianfranco; Gorostidi Manuel; de la Cruz Juan J; Sobrino Javier; Llisterri José L; Alonso Javier; Vinyoles Ernest; Pallarés Vicente; Sarría Antonio; Aranda Pedro; Ruilope Luis M;
Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients.
Hypertension 2009;53(3):466-72.
2009: Banegas José R; Jovell Albert; Abarca Benjamín; Aguilar Diosdado Manuel; Aguilera Luis; Aranda Pedro; Bertoméu Vicente; Capilla Pedro; Conthe Pedro; De Alvaro Fernando; Fernández-Pro Antonio; Formiguera Xavier; Frías Jesús; Guerrero Lucía; Llisterri José L; Lobos José M; Macías Juan F; Martín De Francisco Angel L; Millán Jesús; Morales Juan C; Palomo Vicente; Roca-Cusachs Alex; Román Javier; Sanchis Carlos; Sarriá Antonio; Segura Julián; De La Sierra Alex; Verde Luis; Zarco Julio; Ruilope Luis M
[Hypertension and health policy in Spain]
Medicina clínica 2009;132(6):222-9.
2009: Waeber Bernard; de la Sierra Alejandro; Ruilope Luis M
The ADVANCE Trial: Clarifying the Role of Perindopril/Indapamide Fixed-Dose Combination in the Reduction of Cardiovascular and Renal Events in Patients with Diabetes Mellitus.
American journal of cardiovascular drugs : drugs, devices, and other interventions 2009;9(5):283-91.
2009: Waeber Bernard; Feihl François; Ruilope Luis M
Fixed-dose combinations as initial therapy for hypertension: a review of approved agents and a guide to patient selection.
Drugs 2009;69(13):1761-76.
2009: Waeber Bernard; Ruilope Luis M
Amlodipine and valsartan as components of a rational and effective fixed-dose combination.
Vascular health and risk management 2009;5(1):165-74.
2008: Banegas José R; Segura Julián; de la Sierra Alejandro; Gorostidi Manuel; Rodríguez-Artalejo Fernando; Sobrino Javier; de la Cruz Juan J; Vinyoles Ernest; del Rey Raquel Hernández; Graciani Auxiliadora; Ruilope Luis M;
Gender differences in office and ambulatory control of hypertension.
The American journal of medicine 2008;121(12):1078-84.
2008: Delles Christian; Raff Ulrike; Mimran Albert; Fauvel Jean P; Ruilope Luis M; Schmieder Roland E
Effects of telmisartan and ramipril on adiponectin and blood pressure in patients with type 2 diabetes.
American journal of hypertension 2008;21(12):1330-6.
2008: Pitt Bertram; Bakris George; Ruilope Luis M; DiCarlo Lorenzo; Mukherjee Robin;
Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS).
Circulation 2008;118(16):1643-50.
2008: Segura Julian; Ruilope Luis M
New guidelines of the European Society of Hypertension.
Current hypertension reports 2008;10(5):337-8.
2008: Segura Julian; Ruilope Luis M
Hyperkalemia risk and treatment of heart failure.
Heart failure clinics 2008;4(4):455-64.
2008: Schmieder Roland E; Ruilope Luis M
Blood pressure control in patients with comorbidities.
Journal of clinical hypertension (Greenwich, Conn.) 2008;10(8):624-31.
2008: Sarafidis Pantelis A; Ruilope Luis M
Insulin resistance, microalbuminuria, and chronic kidney disease.
Current hypertension reports 2008;10(4):249-51.
2008: Parati Gianfranco; Stergiou George S; Asmar Roland; Bilo Grzegorz; de Leeuw Peter; Imai Yutaka; Kario Kazuomi; Lurbe Empar; Manolis Athanasios; Mengden Thomas; O'Brien Eoin; Ohkubo Takayoshi; Padfield Paul; Palatini Paolo; Pickering Thomas; Redon Josep; Revera Miriam; Ruilope Luis M; Shennan Andrew; Staessen Jan A; Tisler Andras; Waeber Bernard; Zanchetti Alberto; Mancia Giuseppe;
European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring.
Journal of hypertension 2008;26(8):1505-26.
2008: Ruilope Luis M; Segura Julian
The importance of integrated risk management when treating patients with hypertension: benefits of angiotensin II receptor antagonist therapy.
Clinical and experimental hypertension (New York, N.Y. : 1993) 2008;30(5):397-414.
2008: Ruilope Luis M
New ADVANCEs in guidelines.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 2008;26(2):S16-8.
2008: Ruilope Luis M; Burnier Michel; Muszbek Noemi; Brown Ruth E; Keskinaslan Abdulkadir; Ferber Philippe; Harms Günter
Public health value of fixed-dose combinations in hypertension.
Blood pressure. Supplement 2008;1():5-14.
2008: de la Sierra Alejandro; Gorostidi Manuel; Marín Rafael; Redón Josep; Banegas José R; Armario Pedro; García Puig Juan; Zarco Julio; Llisterri José L; Sanchís Carlos; Abarca Benjamín; Palomo Vicente; Gomis Ramón; Otero Alfonso; Villar Fernando; Honorato Jesús; Tamargo Juan; Lobos José M; Macías-Núñez Juan; Sarría Antonio; Aranda Pedro; Ruilope Luis M
[Evaluation and management of hypertension in Spain. A consensus guide]
Medicina clínica 2008;131(3):104-16.
2008: Ruilope Luis M
New ADVANCEs in guidelines.
Journal of hypertension 2008;26 Suppl 2():S16-8.
2008: Ruilope Luis M; Schmieder Roland E
Left ventricular hypertrophy and clinical outcomes in hypertensive patients.
American journal of hypertension 2008;21(5):500-8.
2008: Ruilope Luis M
Angiotensin receptor blockers: RAAS blockade and renoprotection.
Current medical research and opinion 2008;24(5):1285-93.
2008: Mohler Emile R; Ballantyne Christie M; Davidson Michael H; Hanefeld Markolf; Ruilope Luis M; Johnson Joel L; Zalewski Andrew;
The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study.
Journal of the American College of Cardiology 2008;51(17):1632-41.
2008: Ruilope Luis M; Després Jean-Pierre; Scheen André; Pi-Sunyer Xavier; Mancia Guiseppe; Zanchetti Alberto; Van Gaal Luc
Effect of rimonabant on blood pressure in overweight/obese patients with/without co-morbidities: analysis of pooled RIO study results.
Journal of hypertension 2008;26(2):357-67.
2008: Ruilope Luis M
Clinical efficacy and safety of olmesartan/hydrochlorothiazide combination therapy in patients with essential hypertension.
Vascular health and risk management 2008;4(6):1237-48.
2008: Ruilope Luis M; Burnier Michel; Muszbek Noemi; Brown Ruth E; Keskinaslan Abdulkadir; Ferber Philippe; Harms Gunter
Public health value of fixed-dose combinations in hypertension.
Blood pressure 2008;17 Suppl 1():5-14.
2007: Hernández-del Rey Raquel; Martin-Baranera Montserrat; Sobrino Javier; Gorostidi Manuel; Vinyoles Ernest; Sierra Cristina; Segura Julian; Coca Antonio; Ruilope Luis Miguel;
Reproducibility of the circadian blood pressure pattern in 24-h versus 48-h recordings: the Spanish Ambulatory Blood Pressure Monitoring Registry.
Journal of hypertension 2007;25(12):2406-12.
2007: Ruilope Luis Miguel; Carmena Rafael
[New targets in patients with cardiometabolic risk]
Medicina clínica 2007;129(15):576-7.
2007: Segura Julian; Ruilope Luis M
Obesity, essential hypertension and renin-angiotensin system.
Public health nutrition 2007;10(10A):1151-5.
2007: Graham Ian; Atar Dan; Borch-Johnsen Knut; Boysen Gudrun; Burell Gunilla; Cifkova Renata; Dallongeville Jean; De Backer Guy; Ebrahim Shah; Gjelsvik Bjørn; Herrmann-Lingen Christoph; Hoes Arno; Humphries Steve; Knapton Mike; Perk Joep; Priori Silvia G; Pyorala Kalevi; Reiner Zeljko; Ruilope Luis; Sans-Menendez Susana; Op Reimer Wilma Scholte; Weissberg Peter; Wood David; Yarnell John; Zamorano José Luis;
European guidelines on cardiovascular disease prevention in clinical practice: executive summary.
Atherosclerosis 2007;194(1):1-45.
2007: Barrios Vivencio; Banegas José R; Ruilope Luis M; Rodicio José L
Evolution of blood pressure control in Spain.
Journal of hypertension 2007;25(9):1975-7.
2007: Mancia Giuseppe; De Backer Guy; Dominiczak Anna; Cifkova Renata; Fagard Robert; Germano Giuseppe; Grassi Guido; Heagerty Anthony M; Kjeldsen Sverre E; Laurent Stephane; Narkiewicz Krzysztof; Ruilope Luis; Rynkiewicz Andrzej; Schmieder Roland E; Boudier Harry Aj Struijker; Zanchetti Alberto;
2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension.
Journal of hypertension 2007;25(9):1751-62.
2007: Segura Julián; García-Donaire José A; Ruilope Luis M
Are differences in calcium antagonists relevant across all stages of nephropathy or only proteinuric nephropathy?
Current opinion in nephrology and hypertension 2007;16(5):422-6.
2007: Segura Julian; Banegas Jose Ramon; García-Donaire Jose Antonio; Rodríguez-Artalejo Fernando; de la Cruz Juan Jose; Praga Manuel; Ruilope Luis Miguel
Should hypertension guidelines be changed for hypertensive patients with the metabolic syndrome?
Journal of clinical hypertension (Greenwich, Conn.) 2007;9(8):595-600.
2007: Ruilope Luis M; Kirwan Bridget-Anne; de Brouwer Sophie; Danchin Nicolas; Fox Keith A A; Wagener Gilbert; Segura Julian; Poole-Wilson Philip A; Lubsen Jacobus;
Uric acid and other renal function parameters in patients with stable angina pectoris participating in the ACTION trial: impact of nifedipine GITS (gastro-intestinal therapeutic system) and relation to outcome.
Journal of hypertension 2007;25(8):1711-8.
2007: Ruilope Luis M
Renal AT 1 receptors and hypertension.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(8):2136-7.
2007: Martín-Baranera Montserrat; Campo Carlos; Coca Antonio; de la Figuera Mariano; Marín Rafael; Ruilope Luis Miguel;
[Stratification and degree of control of cardiovascular risk factors in hypertensive Spanish population. Results of the DICOPRESS study]
Medicina clínica 2007;129(7):247-51.
2007: de la Sierra Alejandro; Ruilope Luis Miguel
Management of cardiovascular risk factors in patients with metabolic syndrome.
Cardiovascular & hematological agents in medicinal chemistry 2007;5(3):209-14.
2007: Ruilope Luis M; Zanchetti Alberto; Julius Stevo; McInnes Gordon T; Segura Julian; Stolt Pelle; Hua Tsushung A; Weber Michael A; Jamerson Ken;
Prediction of cardiovascular outcome by estimated glomerular filtration rate and estimated creatinine clearance in the high-risk hypertension population of the VALUE trial.
Journal of hypertension 2007;25(7):1473-9.
2007: Sierra Cristina; De la Sierra Alejandro; Sobrino Javier; Segura Julián; Banegas José Ramón; Gorostidi Manuel; Ruilope Luis Miguel;
[Ambulatory blood pressure monitoring (CABPM): clinical characteristics of 31,530 patients]
Medicina clínica 2007;129(1):1-5.
2007: Schmieder Roland E; Delles Christian; Mimran Albert; Fauvel Jean P; Ruilope Luis M
Impact of telmisartan versus ramipril on renal endothelial function in patients with hypertension and type 2 diabetes.
Diabetes care 2007;30(6):1351-6.
2007: Barrios V; Escobar C; Calderón A; Echarri R; González-Pedel V; Ruilope L M;
Cardiovascular risk profile and risk stratification of the hypertensive population attended by general practitioners and specialists in Spain. The CONTROLRISK study.
Journal of human hypertension 2007;21(6):479-85.
2007: Gorostidi Manuel; Sobrino Javier; Segura Julián; Sierra Cristina; de la Sierra Alex; Hernández del Rey Raquel; Vinyoles Ernest; Galcerán Josep M; López-Eady María D; Marín Rafael; Banegas José R; Sarría Antonio; Coca Antonio; Ruilope Luis M;
Ambulatory blood pressure monitoring in hypertensive patients with high cardiovascular risk: a cross-sectional analysis of a 20,000-patient database in Spain.
Journal of hypertension 2007;25(5):977-84.
2007: García Donaire José A; Ruilope Luis M
Angiotensin receptor blockade in diabetic renal disease--focus on candesartan.
Diabetes research and clinical practice 2007;76 Suppl 1():S22-30.
2007: Weber Michael A; Ruilope Luis; Giles Thomas D; Izzo Joseph L
First-step use of fixed-dose combination treatment in stage 2 hypertensive patients: has the time come?
Journal of clinical hypertension (Greenwich, Conn.) 2007;9(4):276-84.
2007: Garcia-Donaire Jose A; Segura Julian; Ruilope Luis M
Clinical trials in nephrology: success or failure.
Current opinion in nephrology and hypertension 2007;16(2):59-63.
2007: Ruilope Luis M; Brotons Carlos
[Primary care and early identification of high cardiovascular risk]
Medicina clínica 2007;128(4):135-6.
2007: Banegas José R; Segura Julián; Sobrino Javier; Rodríguez-Artalejo Fernando; de la Sierra Alejandro; de la Cruz Juan J; Gorostidi Manuel; Sarría Antonio; Ruilope Luis M;
Effectiveness of blood pressure control outside the medical setting.
Hypertension 2007;49(1):62-8.
2007: Mansia Giuseppe; De Backer Guy; Dominiczak Anna; Cifkova Renata; Fagard Robert; Germano Giuseppe; Grassi Guido; Heagerty Anthony M; Kjeldsen Sverre E; Laurent Stephane; Narkiewicz Krzysztof; Ruilope Luis; Rynkiewicz Andrzej; Schmieder Roland E; Struijker Boudier Harry A; Zanchetti Alberto;
2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
Blood pressure 2007;16(3):135-232.
2007: Macías J; Robles N R; Herrera J; Ayus J C; Calabria F; Domínguez A; Ferder L; Grande Villoria J; Guillén F; Ingaramo R; Juncos L; López-Dóriga P; López Novoa J M; Martell N; Martínez Maldonado M; Núñez A; Prado F; Pupi L M; Ribera J M; Roldán C; Rodicio J L; Ruilope L M; Rodrigo A; Waisman G;
[Recommendations for diagnosis and treatment of aged hypertensives]
Nefrología : publicación oficial de la Sociedad Española Nefrologia 2007;27(3):270-8.
2007: Ruilope Luis; Kjeldsen Sverre E; de la Sierra Alejandro; Mancia Giuseppe; Ruggenenti Piero; Stergiou George S; Bakris George L; Giles Thomas D
The kidney and cardiovascular risk--implications for management: a consensus statement from the European Society of Hypertension.
Blood pressure 2007;16(2):72-9.
2007: García Donaire José A; Ruilope Luis M
Trandolapril/verapamil combination in hypertensive diabetic patients.
Vascular health and risk management 2007;3(1):77-82.
2007: Ruilope Luis Miguel; Redón Josep; Schmieder Roland
Cardiovascular risk reduction by reversing endothelial dysfunction: ARBs, ACE inhibitors, or both? Expectations from the ONTARGET Trial Programme.
Vascular health and risk management 2007;3(1):1-9.
2006: Gomez Pablo; Ruilope Luis Miguel; Barrios Vivencio; Navarro Jorge; Prieto Miguel Angel; Gonzalez Olga; Guerrero Lucía; Zamorano Miguel Angel Sanchez; Filozof Claudia;
Prevalence of renal insufficiency in individuals with hypertension and obesity/overweight: the FATH study.
Journal of the American Society of Nephrology : JASN 2006;17(12 Suppl 3):S194-200.
2006: Segura Julián; Ruilope Luis M
Main issues for achieving blood pressure goals.
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(11):766-7.
2006: Ruilope Luis M; Segura Julian
Predictors of the evolution of microalbuminuria.
Hypertension 2006;48(5):832-3.
2006: Bakris George L; Ruilope Luis M; McMorn Stephen O; Weston Wayde M; Heise Mark A; Freed Martin I; Porter Lisa E
Rosiglitazone reduces microalbuminuria and blood pressure independently of glycemia in type 2 diabetes patients with microalbuminuria.
Journal of hypertension 2006;24(10):2047-55.
2006: Segura Julian; Ruilope Luis Miguel
Antihypertensive therapy in patients with metabolic syndrome.
Current opinion in nephrology and hypertension 2006;15(5):493-7.
2006: Bakris G L; Ruilope L; Locatelli F; Ptaszynska A; Pieske B; Raz I; Voors A A; Dechamplain J; Weber M A
Rationale and design of a study to evaluate management of proteinuria in patients at high risk for vascular events: the IMPROVE trial.
Journal of human hypertension 2006;20(9):693-700.
2006: Banegas José R; Guallar-Castillón Pilar; Rodríguez-Artalejo Fernando; Graciani Auxiliadora; López-García Esther; Ruilope Luis M
Association between awareness, treatment, and control of hypertension, and quality of life among older adults in Spain.
American journal of hypertension 2006;19(7):686-93.
2006: Ruilope Luis M; Zanchetti Alberto
Targeting hypertension with valsartan: Lessons learned from the Valsartan/HCTZ versus Amlodipine in stage II hypertensive patients (VASt) trial.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2006;7 Suppl 1():S8-11.
2006: Erdine Serap; Ari Oben; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn K H; Rodicio J L; Ruilope L M; Staessen J; van Zwieten P; Waeber B; Williams B
ESH-ESC guidelines for the management of hypertension.
Herz 2006;31(4):331-8.
2006: Ruilope Luis M; Segura Julian
Renal protection in diabetic patients: benefits of a first-line combination of perindopril-indapamide (Preterax).
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 2006;24(3):S9-12.
2006: Segura Julian; Roldán Cecilia; García-Donaire Jose A; Ruilope Luis M
Prediabetes and cardiovascular risk in hypertensive patients.
Current hypertension reports 2006;8(2):97-100.
2006: Segura Julian; García-Donaire Jose A; Praga Manuel; Ruilope Luis M
Chronic kidney disease as a situation of high added risk in hypertensive patients.
Journal of the American Society of Nephrology : JASN 2006;17(4 Suppl 2):S136-40.
2006: García-Puig Juan; Ruilope Luis M; Luque Manuel; Fernández Jaime; Ortega Rafael; Dal-Ré Rafael;
Glucose metabolism in patients with essential hypertension.
The American journal of medicine 2006;119(4):318-26.
2006: Palatini Paolo; Benetos Athanase; Grassi Guido; Julius Stevo; Kjeldsen Sverre E; Mancia Giuseppe; Narkiewicz Krzystof; Parati Gianfranco; Pessina Achille C; Ruilope Luis M; Zanchetti Alberto;
Identification and management of the hypertensive patient with elevated heart rate: statement of a European Society of Hypertension Consensus Meeting.
Journal of hypertension 2006;24(4):603-10.
2006: Ruilope Luis M; Segura Julian
Blood pressure lowering or selection of antihypertensive agent: which is more important?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006;21(4):843-5.
2006: Garcia-Donaire Jose A; Ruilope Luis M
Spotlight on renin: cardiovascular outcomes in chronic kidney disease and suppression of the renin-angiotensin system.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2006;7(1):56-8.
2006: Haffner Steve M; Ruilope Luis; Dahlöf Björn; Abadie Eric; Kupfer Stuart; Zannad Faiez
Metabolic syndrome, new onset diabetes, and new end points in cardiovascular trials.
Journal of cardiovascular pharmacology 2006;47(3):469-75.
2006: Haller Hermann; Viberti Gian C; Mimran Albert; Remuzzi Giuseppe; Rabelink Antonius J; Ritz Eberhard; Rump Lars C; Ruilope Luis M; Katayama Shigehiro; Ito Sadayoshi; Izzo Joseph L; Januszewicz Andrzej
Preventing microalbuminuria in patients with diabetes: rationale and design of the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study.
Journal of hypertension 2006;24(2):403-8.
2006: Marín Rafael; Fernández-Vega Francisco; Gorostidi Manuel; Ruilope Luis M; Díez Javier; Praga Manuel; Herrero Pablo; Alcázar Jose M; Laviades Concepción; Aranda Pedro;
Blood pressure control in patients with chronic renal insufficiency in Spain: a cross-sectional study.
Journal of hypertension 2006;24(2):395-402.
2006: Suárez Carmen; Villar José; Martel Nieves; Extremera Blas Gil; Suliman Najaty; Campo Carlos; Castellanos Victoriano; Liébana Antonio; Rodilla Enrique; Nieto Javier; Velasco Olga; Ruilope Luis M;
Should we perform an echocardiogram in hypertensive patients classified as having low and medium risk?
International journal of cardiology 2006;106(1):41-6.
2006: Sarafidis Pantelis A; Ruilope Luis M
Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications.
American journal of nephrology 2006;26(3):232-44.
2005: Aranda Pedro; Segura Julian; Ruilope Luis M; Aranda Francisco J; Frutos Miguel A; López Verónica; López de Novales Eduardo
Long-term renoprotective effects of standard versus high doses of telmisartan in hypertensive nondiabetic nephropathies.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2005;46(6):1074-9.
2005: Segura Julián; Campo Carlos; Ruilope Luis M; Rodicio José L
Do we need to target 'prediabetic' hypertensive patients?
Journal of hypertension 2005;23(12):2119-25.
2005: Ruilope Luis M; Segura Julian
Advantages of new cardiovascular risk-assessment strategies in high-risk patients with hypertension.
Clinical therapeutics 2005;27(10):1658-68.
2005: Campo C; Saavedra J; Segura J; Roldán C; Ruilope L M; Parati G
Correlations of smoothness index and trough-to-peak ratio with left ventricular mass index changes induced by lercanidipine in hypertensive patients. A pilot trial.
Minerva medica 2005;96(5):365-71.
2005: Ruilope Luis Miguel; Tamargo Juan
[Effectiveness and safety of calcium antagonists in hypertensive patients]
Medicina clínica 2005;125(11):412-4.
2005: Ruilope Luis M
Renal function and cardiovascular risk in hypertensive patients.
Journal of hypertension 2005;23(10):1787-8.
2005: Ruilope Luis M
The launch of the Renin Academy.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2005;6(2):49.
2005: Weinberger Myron H; White William B; Ruilope Luis-Miguel; MacDonald Thomas M; Davidson Robert C; Roniker Barbara; Patrick Jeffrey L; Krause Scott L
Effects of eplerenone versus losartan in patients with low-renin hypertension.
American heart journal 2005;150(3):426-33.
2005: García-Donaire Jose Antonio; Segura Julian; Ruilope Luis Miguel
An update of irbesartan and renin-angiotensin system blockade in diabetic nephropathy.
Expert opinion on pharmacotherapy 2005;6(9):1587-96.
2005: Segura Julian; Ruilope Luis M
Minor abnormalities of renal function: a situation requiring integrated management of cardiovascular risk.
Fundamental & clinical pharmacology 2005;19(4):429-37.
2005: Ruilope Luis M; Malacco Ettore; Khder Yasser; Kandra Albert; Bönner Gerd; Heintz Daniela
Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Clinical therapeutics 2005;27(5):578-87.
2005: Volpe M; Ruilope L M; McInnes G T; Waeber B; Weber M A
Angiotensin-II receptor blockers: benefits beyond blood pressure reduction?
Journal of human hypertension 2005;19(5):331-9.
2005: Ruilope L M
Renin-angiotensin-aldosterone system blockade and renal protection: angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers?
Acta diabetologica 2005;42 Suppl 1():S33-41.
2005: Ruilope Luis M; Heintz Daniela; Brandão Andrea A; Stolt Pelle; Kandra Albert; Santonastaso Massimo; Khder Yasser
24-hour ambulatory blood-pressure effects of valsartan and hydrochlorothiazide combinations compared with amlodipine in hypertensive patients at increased cardiovascular risk: a VAST sub-study.
Blood pressure monitoring 2005;10(2):85-91.
2005: Segura Julián; García-Donaire José A; Ruilope Luis M
Calcium channel blockers and renal protection: insights from the latest clinical trials.
Journal of the American Society of Nephrology : JASN 2005;16 Suppl 1():S64-6.
2005: Alvarez-Sala Luis A; Suárez Carmen; Mantilla Teresa; Franch Josep; Ruilope Luis M; Banegas José R; Barrios Vivencio;
[PREVENCAT study: control of cardiovascular risk in primary care]
Medicina clínica 2005;124(11):406-10.
2005: Segura J; Campo C; Ruilope L M
Influence of chronic kidney disease development and renin-angiotensin system inhibition on cardiovascular prognosis.
Current medicinal chemistry. Cardiovascular and hematological agents 2005;3(1):55-60.
2005: Ruilope Luis M; Rosei Enrico Agabiti; Bakris George L; Mancia Giuseppe; Poulter Neil R; Taddei Stefano; Unger Thomas; Volpe Massimo; Waeber Bernard; Zannad Faiez
Angiotensin receptor blockers: therapeutic targets and cardiovascular protection.
Blood pressure 2005;14(4):196-209.
2004: Ruilope Luis M; Segura Julián
Hope in Life and Value of blood pressure control.
Journal of hypertension 2004;22(12):2265-6.
2004: de Leeuw Peter W; Ruilope Luis M; Palmer Christopher R; Brown Morris J; Castaigne Alain; Mancia Giuseppe; Rosenthal Talma; Wagener Gilbert
Clinical significance of renal function in hypertensive patients at high risk: results from the INSIGHT trial.
Archives of internal medicine 2004;164(22):2459-64.
2004: Volpe Massimo; Alderman Michael H; Furberg Curt D; Jackson Rodney; Kostis John B; Laragh John H; Psaty Bruce M; Ruilope Luis M
Beyond hypertension toward guidelines for cardiovascular risk reduction.
American journal of hypertension 2004;17(11 Pt 1):1068-74.
2004: Segura Julian; Campo Carlos; Ruilope Luis M
Effect of proteinuria and glomerular filtration rate on cardiovascular risk in essential hypertension.
Kidney international. Supplement 2004;(92):S45-9.
2004: Christiansen Helle; Segura Julian; Ruilope Luis M
Renal endpoints in hypertension trials.
Clinical and experimental hypertension (New York, N.Y. : 1993) 2004;26(7-8):721-6.
2004: Segura J; Ruilope L M; Rodicio J L
Microalbuminuria.
Clinical and experimental hypertension (New York, N.Y. : 1993) 2004;26(7-8):701-7.
2004: Puig Juan G; Torres Rosa J; Ruilope Luis M; Campo C; Grande Cristina; Sancho Teresa; Bernardino José I
The pathophysiology of hyperuricemia in essential hypertension: a pilot study.
Nucleosides, nucleotides & nucleic acids 2004;23(8-9):1197-9.
2004: Segura J; Campo C; Ruilope L M
Chronic kidney disease and global cardiovascular risk in essential hypertension.
Minerva medica 2004;95(5):375-83.
2004: Ruilope L M; Volpe M
The case for blood pressure control in risk groups.
International journal of clinical practice 2004;58(9):844-9.
2004: Redon Josep; Ruilope Luis M
Microalbuminuria as an intermediate endpoint in essential hypertension: evidence is coming.
Journal of hypertension 2004;22(9):1679-81.
2004: Segura Julian; Ruilope Luis M; Zanchetti Alberto
On the importance of estimating renal function for cardiovascular risk assessment.
Journal of hypertension 2004;22(9):1635-9.
2004: García-Donaire José A; Núñez Antonio Gil; Segura Julián; Ruilope Luis M
Cerebrovascular protection and antihypertensive therapy.
Current opinion in nephrology and hypertension 2004;13(5):507-12.
2004: Segura Julián; Campo Carlos; García-Donaire José A; Ruilope Luis M
Development of chronic kidney disease in essential hypertension during long-term therapy.
Current opinion in nephrology and hypertension 2004;13(5):495-500.
2004: Sierra C; Ruilope Luis M
Novel antihypertensive agents.
Expert opinion on investigational drugs 2004;13(8):987-98.
2004: Segura Julián; Campo Carlos; Gil Paloma; Roldán Cecilia; Vigil Luis; Rodicio José L; Ruilope Luis M
Development of chronic kidney disease and cardiovascular prognosis in essential hypertensive patients.
Journal of the American Society of Nephrology : JASN 2004;15(6):1616-22.
2004: Banegas José R; Segura Julián; Ruilope Luis M; Luque Manuel; García-Robles Rafael; Campo Carlos; Rodríguez-Artalejo Fernando; Tamargo Juan;
Blood pressure control and physician management of hypertension in hospital hypertension units in Spain.
Hypertension 2004;43(6):1338-44.
2004: Calvo Carlos; Hermida Ramón C; Ayala Diana E; Ruilope Luis M
Effects of telmisartan 80 mg and valsartan 160 mg on ambulatory blood pressure in patients with essential hypertension.
Journal of hypertension 2004;22(4):837-46.
2004: Williams Gordon H; Burgess Ellen; Kolloch Rainer E; Ruilope Luis Miguel; Niegowska Joanna; Kipnes Mark S; Roniker Barbara; Patrick Jeffrey L; Krause Scott L
Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertension.
The American journal of cardiology 2004;93(8):990-6.
2004: Sierra Cristina; Ruilope Luis M
Role of the selective aldosterone receptor blockers in arterial hypertension.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2004;5(1):23-5.
2004: Ruilope L M
What is the impact of PRIME on real-life diabetic nephropathy?
International journal of clinical practice 2004;58(3):268-76.
2004: Ruilope Luis M
New European guidelines for management of hypertension: what is relevant for the nephrologist.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004;19(3):524-8.
2004: Aranda Pedro; Ruilope Luis M; Calvo Carlos; Luque Manuel; Coca Antonio; Gil de Miguel Angel
Erectile dysfunction in essential arterial hypertension and effects of sildenafil: results of a Spanish national study.
American journal of hypertension 2004;17(2):139-45.
2004: Ruilope Luis M; Usan Luis; Segura Julián; Bakris George L
Intervention at lower blood pressure levels to achieve target goals in type 2 diabetes: PRADID (PResión Arterial en DIabéticos tipo Dos) study.
Journal of hypertension 2004;22(1):217-22.
2004: Segura Julián; Campo Carlos; Roldán Cecilia; Christiansen Helle; Vigil Luis; García-Robles Rafael; Rodicio José L; Ruilope Luis M
Hypertensive renal damage in metabolic syndrome is associated with glucose metabolism disturbances.
Journal of the American Society of Nephrology : JASN 2004;15 Suppl 1():S37-42.
2004: Mancia Guiseppe; Ruilope Luis; Palmer Christopher; Brown Morris; Castaigne Alain; De Leeuw Peter; Rosental Talma; Wagener Gilbert
Effects of nifedipine GITS and diuretics in isolated systolic hypertension--a subanalysis of the INSIGHT study.
Blood pressure 2004;13(5):310-5.
2003: Campo Carlos; Segura Julian; Roldán Cecilia; Alcázar José M; Rodicio José L; Ruilope Luis M
Doxazosin GITS versus hydrochlorothiazide as add-on therapy in patients with uncontrolled hypertension.
Blood pressure. Supplement 2003;2():16-21.
2003: Ruilope Luis M; Segura Julian
Losartan and other angiotensin II antagonists for nephropathy in type 2 diabetes mellitus: a review of the clinical trial evidence.
Clinical therapeutics 2003;25(12):3044-64.
2003: Cifkova R; Erdine S; Fagard R; Farsang C; Heagerty A M; Kiowski W; Kjeldsen S; Lüscher T; Mallion J M; Mancia G; Poulter N; Rahn K H; Rodicio J L; Ruilope L M; van Zwieten P; Waeber B; Williams B; Zanchetti A;
Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines.
Journal of hypertension 2003;21(10):1779-86.
2003: Segura Julian; Christiansen Helle; Campo Carlos; Ruilope Luis M
How to titrate ACE inhibitors and angiotensin receptor blockers in renal patients: according to blood pressure or proteinuria?
Current hypertension reports 2003;5(5):426-9.
2003: Sierra Cristina; Ruilope Luis M
New-onset diabetes and antihypertensive therapy: comments on ALLHAT trial.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2003;4(3):169-70.
2003: Ruilope Luis M
Lessons from trials in hypertensive type 2 diabetic patients.
Current hypertension reports 2003;5(4):322-8.
2003: Ruilope Luis M; Segura Julián; Campo Carlos; Rodicio José L
Renal participation in cardiovascular risk in essential hypertension.
Expert review of cardiovascular therapy 2003;1(2):309-15.
2003: Volpe Massimo; Cosentino Francesco; Ruilope Luis M
Is it time to measure microalbuminuria in hypertension?
Journal of hypertension 2003;21(7):1213-20.
2003: Ruilope Luis M; Segura Julian; Schiffrin Ernesto L
ACE inhibition or angiotensin receptor blockade: which should we use in diabetic patients?
Journal of the renin-angiotensin-aldosterone system : JRAAS 2003;4(2):74-9.
2003: Mogensen Carl Erik; Viberti Giancarlo; Halimi Serge; Ritz Eberhard; Ruilope Luis; Jermendy György; Widimsky Jiri; Sareli Pinchas; Taton Jan; Rull Juan; Erdogan Gürbüz; De Leeuw Pieter W; Ribeiro Arthur; Sanchez Ramiro; Mechmeche Rachid; Nolan John; Sirotiakova Jana; Hamani Ahmed; Scheen André; Hess Bernhard; Luger Anton; Thomas Stephen M;
Effect of low-dose perindopril/indapamide on albuminuria in diabetes: preterax in albuminuria regression: PREMIER.
Hypertension 2003;41(5):1063-71.
2003: Palmer Christopher R; Brown Morris J; Mancia Giuseppe; Ruilope Luis M;
Long-term cardiovascular consequences of diuretics vs calcium channel blockers vs angiotensin-converting enzyme inhibitors.
JAMA : the journal of the American Medical Association 2003;289(16):2066-7; author reply 2069-70.
2003: Coca A; Ruilope L M; Calvo C; de la Sierra A; Aranda P; Luque M; Marín-Iranzo R;
[Effect of anti-hypertensive therapy with irbesartan on the absolute cardiovascular risk]
Revista clínica española 2003;203(4):183-8.
2003: Ruilope Luis M
Recent developments in the treatment of type 2 diabetes mellitus.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2003;17(2):151-8.
2003: Segura Juliá; Praga Manuel; Campo Carlos; Rodicio José L; Ruilope Luis M
Combination is better than monotherapy with ACE inhibitor or angiotensin receptor antagonist at recommended doses.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2003;4(1):43-7.
2003: Mancia Giuseppe; Brown Morris; Castaigne Alain; de Leeuw Peter; Palmer Christopher R; Rosenthal Talma; Wagener Gilbert; Ruilope Luis M;
Outcomes with nifedipine GITS or Co-amilozide in hypertensive diabetics and nondiabetics in Intervention as a Goal in Hypertension (INSIGHT).
Hypertension 2003;41(3):431-6.
2003: Banegas José R; Ruilope Luis M
[Epidemic of metabolic diseases. A warning call]
Medicina clínica 2003;120(3):99-100.
2003: Ruilope Luis M
Comments on the renal aspects of the ALLHAT study.
Journal of hypertension 2003;21(2):235-6.
2003: Ruilope Luis; Jäger Bodo
Eprosartan for the treatment of hypertension.
Expert opinion on pharmacotherapy 2003;4(1):107-14.
2003: Campo Carlos; Ruilope Luis M; Segura Julian; Rodicio José L; García-Robles Rafael; Garcia-Puig Juan
Hyperuricemia, low urine urate excretion and target organ damage in arterial hypertension.
Blood pressure 2003;12(5-6):277-83.
2002: Ruilope Luis M; Segura Julian
Cardiovascular therapy in patients with renal insufficiency.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2002;16(6):497-501.
2002: Ruilope Luis Miguel; Luño José
Angiotensin blockade in type 2 diabetic renal disease.
Kidney international. Supplement 2002;(82):S61-3.
2002: Ruilope Luis M
The kidney as a sensor of cardiovascular risk in essential hypertension.
Journal of the American Society of Nephrology : JASN 2002;13 Suppl 3():S165-8.
2002: Banegas José R; Rodríguez-Artalejo Fernando; Ruilope Luis M; Graciani Auxiliadora; Luque Manuel; de la Cruz-Troca Juan J; García-Robles Rafael; Tamargo Juan; Rey-Calero Juan
Hypertension magnitude and management in the elderly population of Spain.
Journal of hypertension 2002;20(11):2157-64.
2002: Zanchetti Alberto; Ruilope Luis M
Antihypertensive treatment in patients with type-2 diabetes mellitus: what guidance from recent controlled randomized trials?
Journal of hypertension 2002;20(11):2099-110.
2002: Segura Julián; Campo Carlos; Ruilope Luis M
Proteinuria: an underappreciated risk factor in cardiovascular disease.
Current cardiology reports 2002;4(6):458-62.
2002: Alderman Michael H; Furberg Curt D; Kostis John B; Laragh John H; Psaty Bruce M; Ruilope Luis M; Volpe Massimo; Jackson Rodney
Hypertension guidelines: criteria that might make them more clinically useful.
American journal of hypertension 2002;15(10 Pt 1):917-23.
2002: Bastuji-Garin Sylvie; Deverly Anne; Moyse Dominique; Castaigne Alain; Mancia Giuseppe; de Leeuw Peter W; Ruilope Luis M; Rosenthal Talma; Chatellier Gilles;
The Framingham prediction rule is not valid in a European population of treated hypertensive patients.
Journal of hypertension 2002;20(10):1973-80.
2002: Ritz Eberhard; Dikow Ralf; Ruilope Luis M
Renal dysfunction as a cardiovascular risk factor.
Current hypertension reports 2002;4(5):365-8.
2002: Hermida Ramón C; Calvo Carlos; Ayala Diana E; Fernández José R; Ruilope Luis M; López José E
Evaluation of the extent and duration of the "ABPM effect" in hypertensive patients.
Journal of the American College of Cardiology 2002;40(4):710-7.
2002: Ruilope Luis M; Segura Julian
Renal protection by antihypertensive therapy.
Current hypertension reports 2002;4(4):324-8.
2002: Ruilope Luis M; Coca Antonio; Banegas José R; Pablos Jose Luis; Luque Manuel
Cyclo-oxygenase-2-specific inhibitors and cardiovascular morbidity.
Current hypertension reports 2002;4(4):261-4.
2002: Segura Julian; Campo Carlos; Ruilope Luis M
Antihypertensive therapy and progression of renal failure.
Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 2002;13(3):266-72.
2002: Puig Juan G; Torres Rosa; Ruilope Luis Miguel
AT1 blockers and uric acid metabolism: are there relevant differences?
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 2002;20(5):S29-31.
2002: Zanchetti Alberto; Hansson Lennart; Leonetti Gastone; Rahn Karl-Heinz; Ruilope Luis; Warnold Ingrid; Wedel Hans
Low-dose aspirin does not interfere with the blood pressure-lowering effects of antihypertensive therapy.
Journal of hypertension 2002;20(5):1015-22.
2002: Ruilope Luis M; Coca Antonio; Volpe Massimo; Waeber Bernard
ACE inhibition and cardiovascular mortality and morbidity in essential hypertension: the end of the search or a need for further investigations?
American journal of hypertension 2002;15(4 Pt 1):367-71.
2002: de Pablos-Velasco Pedro Luis; Pazos Toral Fernando; Esmatjes Juan E; Fernandez-Vega Francisco; Lopez de la Torre Martín Lopez; Pozuelo Antonio; Ruilope Luis M
Losartan titration versus diuretic combination in type 2 diabetic patients.
Journal of hypertension 2002;20(4):715-9.
2002: Dzau Victor J; Bernstein Kenneth; Celermajer David; Cohen Jerome; Dahlöf Björn; Deanfield John; Diez Javier; Drexler Helmut; Ferrari Roberto; Van Gilst Wiek; Hansson Lennart; Hornig Burkhard; Husain Ahsan; Johnston Colin; Lazar Harold; Lonn Eva; Lüscher Thomas; Mancini John; Mimran Albert; Pepine Carl; Rabelink Ton; Remme Willem; Ruilope Luis; Ruzicka Marcel; Schunkert Heribert; Swedberg Karl; Unger Thomas; Vaughan Douglas; Weber Michael
Pathophysiologic and therapeutic importance of tissue ACE: a consensus report.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2002;16(2):149-60.
2002: Ruilope Luis Miguel; Esmatjes Enric
[Renal function protection in type 2 diabetic patients]
Medicina clínica 2002;118(8):297-8.
2002: Ruilope Luis Miguel; Coca Antonio
[Selective inhibitors of cyclooxigenase-2 (Coxibs) and cardiovascular morbidity]
Medicina clínica 2002;118(6):219-21.
2002: Kostis John B; Cobbe Stuart; Johnston Colin; Ford Ian; Murphy Michael; Weber Michael A; Black Henry R; Plouin Pierre Francois; Levy Daniel; Mancia Guiseppe; Larochelle Pierre; Kolloch Rainer E; Alderman Michael; Ruilope Luis Miguel; Dahlöf Björn; Flack John M; Wolf Robert;
Design of the Omapatrilat in Persons with Enhanced Risk of Atherosclerotic events (OPERA) trial.
American journal of hypertension 2002;15(2 Pt 1):193-8.
2002: Oubiña M Pilar; de Las Heras Natalia; Vázquez-Pérez Sandra; Cediel Eva; Sanz-Rosa David; Ruilope Luis M; Cachofeiro Victoria; Lahera Vicente
Valsartan improves fibrinolytic balance in atherosclerotic rabbits.
Journal of hypertension 2002;20(2):303-10.
2002: Campo Carlos; Segura Julián; Ruilope Luis M
Factors influencing the systolic blood pressure response to drug therapy.
Journal of clinical hypertension (Greenwich, Conn.) 2002;4(1):35-40.
2002: Ruilope Luis M; Garcia-Robles Rafael; Moreno Basilio
Obesity, cardiovascular risk and pharmacotherapy.
Blood pressure 2002;11(5):260-2.
2002: Barrios Vivencio; Calderón Alberto; Navarro-Cid Josefa; Lahera Vicente; Ruilope Luis M
N-acetylcysteine potentiates the antihypertensive effect of ACE inhibitors in hypertensive patients.
Blood pressure 2002;11(4):235-9.
2002: Barrios Vivencio; Navarro Angel; Esteras Antonio; Luque Manuel; Romero Joaquima; Tamargo Juan; Prieto Luis; Carrasco Jose Luis; Herranz Inmaculada; Navarro-Cid Josefa; Ruilope Luis M;
Antihypertensive efficacy and tolerability of lercanidipine in daily clinical practice. The ELYPSE Study. Eficacia de Lercanidipino y su Perfil de Seguridad.
Blood pressure 2002;11(2):95-100.
2002: Ruilope Luis M
Long-term protection in at-risk hypertensive patients--a role for nifedipine GITS?
Blood pressure 2002;11(2):106-9.
2001: Ruilope L M; van Veldhuisen D J; Ritz E; Luscher T F
Renal function: the Cinderella of cardiovascular risk profile.
Journal of the American College of Cardiology 2001;38(7):1782-7.
2001: Dzau V J; Bernstein K; Celermajer D; Cohen J; Dahlöf B; Deanfield J; Diez J; Drexler H; Ferrari R; van Gilst W; Hansson L; Hornig B; Husain A; Johnston C; Lazar H; Lonn E; Lüscher T; Mancini J; Mimran A; Pepine C; Rabelink T; Remme W; Ruilope L; Ruzicka M; Schunkert H; Swedberg K; Unger T; Vaughan D; Weber M;
The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data.
The American journal of cardiology 2001;88(9A):1L-20L.
2001: Bello E; Caramelo C; Martell N; Alcázar J M; González J; López M D; Ruilope L M; González F R; Rovira A M; Gazapo R; Soldevilla M J; Casado S
Impairment of renal vasodilation with l-arginine is related to more severe disease in untreated hypertensive patients.
Hypertension 2001;38(4):907-12.
2001: Ruilope L M; Campo C; Segura J
The calcium channel blocker controversy in patients with diabetic nephropathy: Is there an issue?
Current hypertension reports 2001;3(5):419-21.
2001: Segura J; Campo C; Rodicio J L; Ruilope L M
ACE inhibitors and appearance of renal events in hypertensive nephrosclerosis.
Hypertension 2001;38(3 Pt 2):645-9.
2001: Ruilope L M; Schiffrin E L
Blood pressure control and benefits of antihypertensive therapy: does it make a difference which agents we use?
Hypertension 2001;38(3 Pt 2):537-42.
2001: Campo C; García Puig J; Segura J; María Alcázar J; García-Robles R; Ruilope L M
[Relationship between severity of essential arterial hypertension and the prevalence hyperuricemia]
Medicina clínica 2001;117(3):85-9.
2001: Ruilope L M
Kidney dysfunction: a sensitive predictor of cardiovascular risk.
American journal of hypertension 2001;14(6 Pt 2):213S-217S.
2001: Zanchetti A; Hansson L; Dahlöf B; Elmfeldt D; Kjeldsen S; Kolloch R; Larochelle P; McInnes G T; Mallion J M; Ruilope L; Wedel H
Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study. HOT Study Group.
Journal of hypertension 2001;19(6):1149-59.
2001: Ruilope L M; Garcia-Puig J
Hyperuricemia and renal function.
Current hypertension reports 2001;3(3):197-202.
2001: Campo C; Segura J; Fernández M L; Guerrero L; Christiansen H; Ruilope L M
A prospective comparison of four antihypertensive agents in daily clinical practice.
Journal of clinical hypertension (Greenwich, Conn.) 2001;3(3):139-44.
2001: Bravo R; Somoza B; Ruiz-Gayo M; González C; Ruilope L M; Fernández-Alfonso M S
Differential effect of chronic antihypertensive treatment on vascular smooth muscle cell phenotype in spontaneously hypertensive rats.
Hypertension 2001;37(5):E4-E10.
2001: Vázquez-Pérez S; Navarro-Cid J; de las Heras N; Cediel E; Sanz-Rosa D; Ruilope L M; Cachofeiro V; Lahera V
Relevance of endothelium-derived hyperpolarizing factor in the effects of hypertension on rat coronary relaxations.
Journal of hypertension 2001;19(3 Pt 2):539-45.
2001: Ruilope L M; Salvetti A; Jamerson K; Hansson L; Warnold I; Wedel H; Zanchetti A
Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study.
Journal of the American Society of Nephrology : JASN 2001;12(2):218-25.
2001: Ruilope L M; Rodicio J L
Renal participation in cardiovascular risk in essential hypertension.
Blood pressure 2001;10(5-6):322-6.
2001: Ruilope L M; Campo C; Segura J; Rodicio J L
What is the optimal blood pressure target in renal patients?
Advances in nephrology from the Necker Hospital 2001;31():43-53.
2001: Ruilope L M; Rodicio J L
The kidney in arterial hypertension.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2001;16 Suppl 1():50-2.
2001: Vázquez-Pérez S; Aragoncillo P; de Las Heras N; Navarro-Cid J; Cediel E; Sanz-Rosa D; Ruilope L M; Díaz C; Hernández G; Lahera V; Cachofeiro V
Atorvastatin prevents glomerulosclerosis and renal endothelial dysfunction in hypercholesterolaemic rabbits.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2001;16 Suppl 1():40-4.
2000: Aragoncillo P; Maeso R; Vázquez-Pérez S; Navarro-Cid J; Ruilope L M; Díaz C; Hernández G; Lahera V; Cachofeiro V
The protective role of atorvastatin on function, structure and ultrastructure in the aorta of dyslipidemic rabbits.
Virchows Archiv : an international journal of pathology 2000;437(5):545-54.
2000: Ruilope L M; Barrios V; Volpe M
Renal implications of the renin-angiotensin-aldosterone system blockade in heart failure.
Journal of hypertension 2000;18(11):1545-51.
2000: Ruilope L
RAS blockade: new possibilities in the treatment of complications of diabetes.
Heart (British Cardiac Society) 2000;84 Suppl 1():i32-4:discussion i50.
2000: Ruilope L M
AT1-receptor blockers and ACE inhibitors: alternatives or partners?
International journal of clinical practice. Supplement 2000;(111):20-4.
2000: Brown M J; Palmer C R; Castaigne A; de Leeuw P W; Mancia G; Rosenthal T; Ruilope L M
Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).
Lancet 2000;356(9227):366-72.
2000: Ruilope L M
New clinical investigations with selective angiotensin II receptor blocker therapy in diabetes and renal disease.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2000;1(2 Suppl):S29-31.
2000: de La Sierra A; Ruilope L M
Treatment of hypertension in diabetes mellitus.
Current hypertension reports 2000;2(3):335-42.
2000: Brown M J; Castaigne A; de Leeuw P W; Mancia G; Palmer C R; Rosenthal T; Ruilope L M
Influence of diabetes and type of hypertension on response to antihypertensive treatment.
Hypertension 2000;35(5):1038-42.
2000: Maeso R; Aragoncillo P; Navarro-Cid J; Ruilope L M; Diaz C; Hernández G; Lahera V; Cachofeiro V
Effect of atorvastatin on endothelium-dependent constrictor factors in dyslipidemic rabbits.
General pharmacology 2000;34(4):263-72.
2000: Ruilope L M; Aldigier J C; Ponticelli C; Oddou-Stock P; Botteri F; Mann J F
Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease.
Journal of hypertension 2000;18(1):89-95.
2000: Campo C; Fernández G; González-Esteban J; Segura J; Ruilope L M;
Comparative study of home and office blood pressure in hypertensive patients treated with enalapril/HCTZ 20/6 mg: the ESPADA study.
Blood pressure 2000;9(6):355-62.
2000: Ruilope L M
Do we effectively lower blood pressure?
Journal of cardiovascular pharmacology 2000;35 Suppl 3():S3-6.
1999: Ruilope L M; de la Sierra A; Moreno E; Fernández R; Garrido J; de la Figuera M; de la Cámara A G; Coca A; Luque-Otero M
Prospective comparison of therapeutical attitudes in hypertensive type 2 diabetic patients uncontrolled on monotherapy. A randomized trial: the EDICTA study.
Journal of hypertension 1999;17(12 Pt 2):1917-23.
1999: Ruilope L M
Is it wise to combine an ACE inhibitor and an angiotensin receptor antagonist?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1999;14(12):2855-6.
1999: Maeso R; Navarro-Cid J; Rodrigo E; Ruilope L M; Lahera V; Cachofeiro V
Differential effects of losartan and doxazosin on vascular function in senescent spontaneously hypertensive rats.
American journal of hypertension 1999;12(11 Pt 1):1105-8.
1999: Suárez C; Cucala M; Coca A; Ruilope L M
[Spanish contribution to the HOT (Hypertension Optimal Treatment) study. Final results. Spanish Investigators in the HOT study]
Medicina clínica 1999;113(10):361-5.
1999: de las Heras N; Aragoncillo P; Maeso R; Vazquez-Pérez S; Navarro-Cid J; DeGasparo M; Mann J; Ruilope L M; Cachofeiro V; Lahera V
AT(1) receptor antagonism reduces endothelial dysfunction and intimal thickening in atherosclerotic rabbits.
Hypertension 1999;34(4 Pt 2):969-75.
1999: Ruilope L M; Rodicio J L
Renal surrogates in essential hypertension.
Clinical and experimental hypertension (New York, N.Y. : 1993) 1999;21(5-6):609-14.
1999: Caramelo C; Bello E; Ruiz E; Rovira A; Gazapo R M; Alcazar J M; Martell N; Ruilope L M; Casado S; Fernández Guerrero M
Hyperkalemia in patients infected with the human immunodeficiency virus: involvement of a systemic mechanism.
Kidney international 1999;56(1):198-205.
1999: Bello E; Caramelo C; López M D; Soldevilla M J; Gonzalez-Pacheco F R; Rovira A; Delgado R G; Alcazar J M; Martell N; González J; Ruilope L M; Casado S
Induction of microalbuminuria by l-arginine infusion in healthy individuals: an insight into the mechanisms of proteinuria.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1999;33(6):1018-25.
1999: Maeso R; Navarro-Cid J; Rodrigo E; Ruilope L M; Cachofeiro V; Lahera V
Effects of antihypertensive therapy on factors mediating endothelium-dependent relaxation in rats treated chronically with L-NAME.
Journal of hypertension 1999;17(2):221-7.
1999: Ruilope L M
The kidney as part of the cardiovascular system.
Journal of cardiovascular pharmacology 1999;33 Suppl 1():S7-10; discussion S41-3.
1998: Rodicio J L; Campo C; Ruilope L M
Microalbuminuria in essential hypertension.
Kidney international. Supplement 1998;68():S51-4.
1998: González-Albarrán O; García Robles R; Ruilope L M
Therapeutic implications and new perspectives for essential hypertension and renal damage.
Kidney international. Supplement 1998;68():S46-50.
1998: Maeso R; Rodrigo E; Muñoz-García R; Navarro-Cid J; Ruilope L M; Cachofeiro V; Lahera V
Factors involved in the effects of losartan on endothelial dysfunction induced by aging in SHR.
Kidney international. Supplement 1998;68():S30-5.
1998: Villa E; Rábano A; Albarrán O G; Ruilope L M; García-Robles R
Effects of chronic combined treatment with captopril and pravastatin on the progression of insulin resistance and cardiovascular alterations in an experimental model of obesity in dogs.
American journal of hypertension 1998;11(7):844-51.
1998: Maeso R; Rodrigo E; Muñoz-García R; Navarro-Cid J; Ruilope L M; Cachofeiro V; Lahera V
Chronic treatment with losartan ameliorates vascular dysfunction induced by aging in spontaneously hypertensive rats.
Journal of hypertension 1998;16(5):665-72.
1998: González-Albarrán O; Ruilope L M; Villa E; García Robles R
Salt sensitivity: concept and pathogenesis.
Diabetes research and clinical practice 1998;39 Suppl():S15-26.
1998: Ruilope L M; García-Robles R
How to treat the diabetic hypertensive individual appropriately.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1998;16(1):S91-3.
1998: Ruilope L M; Coca A
The role of combination therapy in the treatment of hypertension.
Blood pressure. Supplement 1998;1():22-6.
1997: Ruilope L
Human pharmacokinetic/pharmacodynamic profile of irbesartan: a new potent angiotensin II receptor antagonist.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1997;15(7):S15-20.
1997: Campo C; Garcia-Vallejo O; Barrios V; Lahera V; Manero M; Esteban E; Rodicio J L; Ruilope L M
The natriuretic effect of nifedipine gastrointestinal therapeutic system remains despite the presence of mild-to-moderate renal failure.
Journal of hypertension 1997;15(12 Pt 2):1803-8.
1997: Maeso R; Rodrigo E; Muñoz-Garcia R; Navarro-Cid J; Ruilope L M; Lahera V; Cachofeiro V
Losartan reduces constrictor responses to endothelin-1 and the thromboxane A2 analogue in aortic rings from spontaneously hypertensive rats: role of nitric oxide.
Journal of hypertension 1997;15(12 Pt 2):1677-84.
1997: Ruilope L M
Renoprotection and renin-angiotensin system blockade in diabetes mellitus.
American journal of hypertension 1997;10(12 Pt 2):325S-331S.
1997: Ruilope L M; Suarez C
How should we treat hypertensive women with cardiac and renal impairment?
American journal of hypertension 1997;10(10 Pt 2):242S-246S.
1997: Ruilope L M
Prevalence of renal disease in elderly hypertensive patients with cardiovascular problems.
Coronary artery disease 1997;8(8-9):483-8.
1997: Andrés A; Morales J M; Praga M; Campo C; Lahera V; García-Robles R; Rodicio J L; Ruilope L M
L-arginine reverses the antinatriuretic effect of cyclosporin in renal transplant patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1997;12(7):1437-40.
1997: Rodrigo E; Maeso R; Muñoz-García R; Navarro-Cid J; Ruilope L M; Cachofeiro V; Lahera V
Endothelial dysfunction in spontaneously hypertensive rats: consequences of chronic treatment with losartan or captopril.
Journal of hypertension 1997;15(6):613-8.
1997: Ruilope L M; García-Robles R
How far should blood pressure be reduced in diabetic hypertensive patients?
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1997;15(2):S63-5.
1997: Ruilope L M
Renal implications of arterial hypertension.
Current opinion in nephrology and hypertension 1997;6(2):152-6.
1997: Villa E; Rábano A; Cazes M; Cloarec A; Ruilope L M; García-Robles R
Effects of UP269-6, a new angiotensin II receptor antagonist, and captopril on the progression of rat diabetic nephropathy.
American journal of hypertension 1997;10(3):275-81.
1997: Villa E; Rábano A; Ruilope L M; García-Robles R
Effects of cicaprost and fosinopril on the progression of rat diabetic nephropathy.
American journal of hypertension 1997;10(2):202-8.
1997: Lahera V; Navarro-Cid J; Cachofeiro V; García-Estañ J; Ruilope L M
Nitric oxide, the kidney, and hypertension.
American journal of hypertension 1997;10(1):129-40.
1997: Ruilope L M
Microalbuminuria as risk in essential hypertension.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1997;12 Suppl 2():2-5.
1996: Maeso R; Navarro-Cid J; Muñoz-García R; Rodrigo E; Ruilope L M; Lahera V; Cachofeiro V
Losartan reduces phenylephrine constrictor response in aortic rings from spontaneously hypertensive rats. Role of nitric oxide and angiotensin II type 2 receptors.
Hypertension 1996;28(6):967-72.
1996: Ruilope L M; Campo C; Rodriguez-Artalejo F; Lahera V; Garcia-Robles R; Rodicio J L
Blood pressure and renal function: therapeutic implications.
Journal of hypertension 1996;14(11):1259-63.
1996: Navarro-Cid J; Maeso R; Rodrigo E; Muñoz-García R; Ruilope L M; Lahera V; Cachofeiro V
Renal and vascular consequences of the chronic nitric oxide synthase inhibition. Effects of antihypertensive drugs.
American journal of hypertension 1996;9(11):1077-83.
1996: García-Robles R; Villa E; Serrano J; Escobar-Morreale H F; Piédrola G; Ruilope L M
Effects of L-arginine infusion on renal hemodynamics and sodium excretion during hypo-, normo-, and hyperinsulinemia, as studied in dogs.
American journal of hypertension 1996;9(7):681-6.
1996: Navarro-Cid J; Maeso R; Perez-Vizcaino F; Casal M C; Cachofeiro V; Ruilope L M; Tamargo J; Lahera V
Effects of antihypertensive drugs on blood pressure and metabolic alterations in the fructose-induced hypertensive rat.
American journal of hypertension 1996;9(7):669-74.
1996: Campo C; Lahera V; Garcia-Robles R; Cachofeiro V; Alcazar J M; Andres A; Rodicio J L; Ruilope L M
Aging abolishes the renal response to L-arginine infusion in essential hypertension.
Kidney international. Supplement 1996;55():S126-8.
1996: Ruilope L M; Simpson R L; Toh J; Arcuri K E; Goldberg A I; Sweet C S
Controlled trial of losartan given concomitantly with different doses of hydrochlorothiazide in hypertensive patients.
Blood pressure 1996;5(1):32-40.
1996: Hernández E; Praga M; Alamo C; Araque A; Morales J M; Alcazar J M; Ruilope L M; Rodicio J L
Lipoprotein(a) and vascular access survival in patients on chronic hemodialysis.
Nephron 1996;72(2):145-9.
1995: Munoz-Garcia R; Maeso R; Rodrigo E; Navarro J; Ruilope L M; Casal M C; Cachofeiro V; Lahera V
Acute renal excretory actions of losartan in spontaneously hypertensive rats: role of AT2 receptors, prostaglandins, kinins and nitric oxide.
Journal of hypertension 1995;13(12 Pt 2):1779-84.
1995: Rodicio J L; Ruilope L M
Assessing renal effects and renal protection.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1995;13(4):S19-25.
1995: Navarro-Cid J; Maeso R; Perez-Vizcaino F; Cachofeiro V; Ruilope L M; Tamargo J; Lahera V
Effects of losartan on blood pressure, metabolic alterations, and vascular reactivity in the fructose-induced hypertensive rat.
Hypertension 1995;26(6 Pt 2):1074-8.
1995: Ruilope L M
Effects of angiotensin converting enzyme inhibitors on the progression of diabetic nephropathy.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1995;13(2):S91-3.
1995: Cachofeiro V; Maeso R; Rodrigo E; Navarro J; Ruilope L M; Lahera V
Nitric oxide and prostaglandins in the prolonged effects of losartan and ramipril in hypertension.
Hypertension 1995;26(2):236-43.
1995: Praga M; Hernández E; Andrés A; León M; Ruilope L M; Rodicio J L
Effects of body-weight loss and captopril treatment on proteinuria associated with obesity.
Nephron 1995;70(1):35-41.
1994: Navarro J; Sanchez A; Sáiz J; Ruilope L M; García-Estan J; Romero J C; Moncada S; Lahera V
Hormonal, renal, and metabolic alterations during hypertension induced by chronic inhibition of NO in rats.
The American journal of physiology 1994;267(6 Pt 2):R1516-21.
1994: Morales J M; Rodriguez-Paternina E; Araque A; Andres A; Hernandez E; Ruilope L M; Rodicio J L
Long-term protective effect of a calcium antagonist on renal function in hypertensive renal transplant patients on cyclosporine therapy: a 5-year prospective randomized study.
Transplantation proceedings 1994;26(5):2598-9.
1994: Ruilope L M
How much does the kidney participate in the origin of primary hypertension?
Blood pressure 1994;3(4):216-8.
1994: Ruilope L M; Lahera V; Alcázar J M; Praga M; Campo C; Rodicio J L
Randomly allocated study of the effects of standard therapy versus ACE inhibition on micro-albuminuria in essential hypertension.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1994;12(4):S59-63.
1994: Ruilope L M; Lahera V; Araque A; Suarez C; Rodicio J L; Romero J C
Electrolyte excretion and sodium intake.
The American journal of the medical sciences 1994;307 Suppl 1():S107-11.
1994: Ruilope L M
Comparison of a new vasodilating beta-blocker, carvedilol, with atenolol in the treatment of mild to moderate essential hypertension.
American journal of hypertension 1994;7(2):129-36.
1994: Ruilope L M; Alcázar J M; Hernández E; Praga M; Lahera V; Rodicio J L
Long-term influences of antihypertensive therapy on microalbuminuria in essential hypertension.
Kidney international. Supplement 1994;45():S171-3.
1994: Ruilope L M; Lahera V; Rodicio J L; Carlos Romero J
Are renal hemodynamics a key factor in the development and maintenance of arterial hypertension in humans?
Hypertension 1994;23(1):3-9.
1994: Ruilope L M; Lahera V; Rodicio J L
Evaluation of the renal effects of calcium antagonists.
Journal of cardiovascular pharmacology 1994;23 Suppl 5():S49-53.
1993: Rodicio J L; Morales J M; Ruilope L M
Lipophilic dihydropyridines provide renal protection from cyclosporin toxicity.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1993;11(6):S21-5.
1993: Robles R G; Villa E; Rábano A; Alvarez E; Martínez J; Ruilope L M; Sancho J M
Effect of cicaprost on the progression of diabetic nephropathy in uninephrectomized streptozotocin-induced diabetic rats.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1993;11(5):S208-9.
1993: Robles R G; Villa E; Santirso R; Martínez J; Ruilope L M; Cuesta C; Sancho J M
Effects of captopril on sympathetic activity, lipid and carbohydrate metabolism in a model of obesity-induced hypertension in dogs.
American journal of hypertension 1993;6(12):1009-15.
1993: Villa E; Martinez J; Ruilope L M; Mampaso F; Sancho J M; Robles R G
Cicaprost, a prostacyclin analog, protects renal function in uninephrectomized dogs in the absence of changes in blood pressure.
American journal of hypertension 1993;6(4):253-7.
1993: Rodicio J L; Morales J M; Alcázar J M; Ruilope L M
Calcium antagonists and renal protection.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1993;11(1):S49-53.
1993: Lahera V; Navarro J; Biondi M L; Ruilope L M; Romero J C
Exogenous cGMP prevents decrease in diuresis and natriuresis induced by inhibition of NO synthesis.
The American journal of physiology 1993;264(2 Pt 2):F344-7.
1993: Ruilope L M; Araque A; Lahera V; Suarez C
Antihypertensive effect of nitrendipine in the hypertensive patient with renal impairment.
Renal failure 1993;15(3):359-63.
1993: Ruilope L M; Campo C; Lahera V
The kidney and arterial hypertension.
Drugs 1993;46 Suppl 2():108-12.
1993: Robles R G; Villa E; Andres A; Martinez J; Ruilope L M; Sancho J M
Natriuretic effects of dopamine agonist drugs in models of reduced renal mass.
Journal of cardiovascular pharmacology 1993;22 Suppl 2():S88-92.
1992: Ruilope L M; Casal M C; Praga M; Alcazar J M; Decap G; Lahera V; Rodicio J L
Additive antiproteinuric effect of converting enzyme inhibition and a low protein intake.
Journal of the American Society of Nephrology : JASN 1992;3(6):1307-11.
1992: Praga M; Hernández E; Montoyo C; Andrés A; Ruilope L M; Rodicio J L
Long-term beneficial effects of angiotensin-converting enzyme inhibition in patients with nephrotic proteinuria.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1992;20(3):240-8.
1992: Ruilope L M; Casal M C; Guerrero L; Alcázar J M; Férnandez M L; Lahera V; Rodicio J L
Sodium intake does not influence the effect of verapamil in hypertensive patients with mild renal insufficiency.
Drugs 1992;44 Suppl 1():94-8.
1991: Redon J; Gomez-Sanchez M A; Baldo E; Casal M C; Fernandez M L; Miralles A; Gomez-Pajuelo C; Rodicio J L; Ruilope L M
Micro-albuminuria is correlated with left ventricular hypertrophy in male hypertensive patients.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1991;9(6):S148-9.
1991: Villa E; Morales M E; Martinez J; de la Fuente A; Hurtado A; Santirso R A; Ruilope L M; Sancho J M; García-Robles R
Acute effects of iloprost on blood pressure, heart rate, renal hemodynamics, diuresis, natriuresis, plasma renin activity and plasma norepinephrine in uninephrectomized hypertensive mongrel dogs.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1991;9(6):S352-3.
1991: Praga M; Borstein B; Andres A; Arenas J; Oliet A; Montoyo C; Ruilope L M; Rodicio J L
Nephrotic proteinuria without hypoalbuminemia: clinical characteristics and response to angiotensin-converting enzyme inhibition.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1991;17(3):330-8.
1991: Ruilope L M; Guerrero L; Casal M C; Alcazar J M; Campo C; Mazuecos A; Fernandez M L; Rodicio J L
Tolerance to nitrendipine in patients with arterial hypertension accompanying chronic renal failure.
Journal of cardiovascular pharmacology 1991;18 Suppl 1():S71-3.
1990: Morales J M; Andrés A; Alvarez C; Prieto C; Ortuño B; Ortuño T; Paternina E R; Hernandez Poblete G; Praga M; Ruilope L M
Calcium channel blockers and early cyclosporine nephrotoxicity after renal transplantation: a prospective randomized study.
Transplantation proceedings 1990;22(4):1733-5.
1990: Rodicio J L; Morales J M; Ruilope L M
Calcium antagonists and the kidney.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1990;5(2):81-6.
1989: Ruilope L M; Oliet A; Alcázar J M; Hernández E; Andrés A; Rodicio J L; García-Robles R; Martínez J; Lahera V; Romero J C
Characterization of the renal effects of an intravenous calcium gluconate infusion in normotensive volunteers.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1989;7(6):S170-1.
1989: Andrés A; García-Robles R; Alcázar J M; Alvarez C; Martínez J; Oliet A; Sancho J; Rodicio J L; Ruilope L M
Diuretic and natriuretic properties of fenoldopam in chronic renal failure.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1989;7(6):S326-7.
1989: Rodicio J L; Praga M; Alcazar J M; Oliet A; Gutierrez-Millet V; Ruilope L M
Effects of angiotensin converting enzyme inhibitors on the progression of renal failure and proteinuria in humans.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1989;7(7):S43-7.
1989: Puras A; Alcázar J M; Miranda B; Oliet A; Rodicio J L; Ruilope L M
[Clinical characteristics of arterial hypertension in the elderly]
Revista clínica española 1989;185(2):69-73.
1989: Puras A; Alcázar J M; Miranda B; Oliet A; Rodicio J L; Ruilope L M
[Treatment of arterial hypertension in the aged]
Medicina clínica 1989;92(7):245-9.
1989: Morales J M; Andrés A; Prieto C; Ortuño B; Estenoz J; Dorado C; Arenas J; Ruilope L M; Fernández-Cruz L; Rodicio J L
Calcium antagonist treatment of recipients minimizes early cyclosporine nephrotoxicity in renal transplantation: a prospective randomized trial.
Transplantation proceedings 1989;21(1 Pt 2):1537-9.
1989: Ruilope L M; Miranda B; Garcia-Robles R; Bigorra J; Oliet A; Alcazar J M; Sancho Rof J; Rodicio J L
Effects of nisoldipine on renal function in normal volunteers and essential hypertensive patients.
Journal of cardiovascular pharmacology 1989;13(1):90-3.
1988: Ruilope L M; Miranda B; Oliet A; Millet V G; Rodicio J L; Romero J C; Raij L
Control of hypertension with the angiotensin converting enzyme inhibitor captopril reduces glomerular proteinuria.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1988;6(4):S467-9.
1988: Prieto C; Morales J M; Miranda B; Ruilope L M; Andrés A; Moreno F; Rodicio J L
Chronic therapy with cyclosporine A does not modify adrenal production of aldosterone in renal transplant patients.
Transplantation proceedings 1988;20(5 Suppl 6):30-1.
1988: Miranda B; Ruilope L M; García Robles R; Alcázar J M; Sancho J; Tover J; Martínez A; Astorga M; Rodicio J L
[Effects of intravenous administration of fenoldopam on blood pressure and renal function in severe arterial hypertension]
Medicina clínica 1988;91(12):445-8.
1988: Ruilope L M; Robles R G; Miranda B; Tovar J; Alcazar J M; Sancho J; Rodicio J L; Martinez A; Astorga A; Beck T
Renal effects of fenoldopam in refractory hypertension.
Journal of hypertension 1988;6(8):665-9.
1988: Morales J M; Andres A; Prieto C; Arenas J; Ortuño B; Praga M; Ruilope L M; Rodicio J L
Severe reversible cyclosporine-induced acute renal failure. A role for urinary PGE2 deficiency?
Transplantation 1988;46(1):163-5.
1988: Ruilope L; Rodicio J; Miranda B; Garcia Robles R; Sancho-Rof J; Romero J C
Renal effects of amino acid infusions in patients with panhypopituitarism.
Hypertension 1988;11(6 Pt 1):557-9.
1988: Morales J M; Andres A; Alcazar J M; Prieto C; Diaz de Tueste I; Ruilope L M; Rodicio J L
Usefulness of fractional excretion of sodium as index of cyclosporine nephrotoxicity in renal transplantation.
Transplantation proceedings 1988;20(3 Suppl 3):691-9.
1988: Nieto J; Alcázar J M; Ruilope L M; Rodicio J L
[Captopril in the treatment of essential hypertension in old age]
Medicina clínica 1988;90(2):50-2.
1988: Morales J M; Andrés A; Prieto C; Martínez M A; Praga M; Ruilope L M; Gutiérrez Millet V; Rodicio J L
Clinical and histological sequence of recurrent focal segmental glomerulosclerosis.
Nephron 1988;48(3):241-2.
1988: Ruilope L M; Miranda B; Oliet A; Alcazar J M; Bigorra J; Rodicio J L
Persistence of the natriuretic effect of calcium entry blockers.
Journal of cardiovascular pharmacology 1988;12 Suppl 4():S136-9.
1987: Garcia-Robles R; Ruilope L M; Tovar J; de Pablos P; Parada J; Hurtado A; Miranda B; Fernandez Vazquez G; Rodicio J L; Sancho J
Dopaminergic modulation of aldosterone secretion in the normal menstrual cycle.
Journal of clinical hypertension 1987;3(4):470-8.
1987: Morales J M; Andres A; Prieto C; Ruilope L M; Alcazar J M; Oliet A; Praga M; Rodicio J L
Fractional excretion of sodium represents an index of cyclosporine nephrotoxicity in the early post-transplant period.
Transplantation proceedings 1987;19(5):4005-7.
1987: Ruilope L M; Rodicio J; Garcia Robles R; Sancho J; Miranda B; Granger J P; Romero J C
Influence of a low sodium diet on the renal response to amino acid infusions in humans.
Kidney international 1987;31(4):992-9.
1987: Praga M; Diaz Rubio P; Morales J M; Cañizares F; Ruilope L M; Gutierrez-Millet V; Nieto J; Rodicio J L
Implications of hypervitaminosis A on the calcium-phosphate metabolism and on blood lipids in hemodialysis.
American journal of nephrology 1987;7(4):281-6.
1987: Andrés A; Praga M; Ruilope L M; Martínez J M; Millet V G; Bello I; Rodicio J L
Partial deficit of hypoxanthine guanine phosphoribosyl transferase presenting as acute renal failure.
Nephron 1987;46(2):179-81.
1987: Praga M; Andrés A; de la Serna J; Ruilope L M; Nieto J; Estenoz J; Millet V G; Arnaiz F; Rodicio J L
Improvement of anaemia with desferrioxamine in haemodialysis patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1987;2(4):243-7.
1987: Garcia-Robles R; Ruilope L M
Pharmacological influences on aldosterone secretion.
Journal of steroid biochemistry 1987;27(4-6):947-51.
1986: Ruilope L M; Garcia Robles R; Paya C; Alcazar J M; Miravalles E; Sancho-Rof J; Rodicio J; Knox F G; Romero J C
Effects of long-term treatment with indomethacin on renal function.
Hypertension 1986;8(8):677-84.
1986: García-Robles R; Ruilope L; Tovar J; de Villa L F; Miranda B; Prieto C; Parada J; Sancho J; Rodicio J L
Dopamine control of aldosterone secretion in end-stage renal failure.
Revista española de fisiología 1986;42(2):257-63.
1986: Ruilope L M; Miranda B; Robles R G; Hammond T G; Sancho J; Romero J C; Rodicio J L
Effect of exogenous angiotensin II infusion after one year of captopril therapy in essential hypertension.
Postgraduate medical journal 1986;62 Suppl 1():90-3.
1985: Gutiérrez Millet V; Nieto Iglesias J; Ruilope L M; Gutiérrez Rodero F; Usera G; Martínez M A; Praga M; Morales J M; Leyva O
[Focal glomerulosclerosis and proteinuria in patients with a functioning single kidney]
Medicina clínica 1985;85(18):737-42.
1985: Nieto J; Gutiérrez Millet V; Gutiérrez Rodero F; Miranda B; Alcázar J M; Bello I; Ruilope L M; Rodicio J L
[Pseudohypoaldosteronism associated with chronic interstitial nephropathy]
Revista clínica española 1985;177(6):290-2.
1985: Praga M; Gutierrez-Millet V; Navas J J; Ruilope L M; Morales J M; Alcazar J M; Bello I; Rodicio J L
Acute worsening of renal function during episodes of macroscopic hematuria in IgA nephropathy.
Kidney international 1985;28(1):69-74.
1985: Nieto J; Gutiérrez Rodero F; Miranda B; Alcázar J M; Gutiérrez Millet V; Ruilope L M; Rodicio J L
[Usefulness of tiapamil, a new calcium antagonist, in the treatment of essential arterial hypertension]
Medicina clínica 1985;85(6):225-7.
1985: Ruilope L; Garcia-Robles R; Paya C; de Villa L F; Miranda B; Morales J M; Parada J; Sancho J; Rodicio J L
Influence of lisuride, a dopaminergic agonist, on the sexual function of male patients with chronic renal failure.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1985;5(3):182-5.
1984: Ruilope L; Paya C; Alcazar J M; Sancho-Rof J; Garcia-Robles R; Rodicio J; Hammond T G; Knox F G; Romero J C
Failure of angiotensin II to reduce plasma renin activity in hypertensive pregnant women.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1984;2(3):S251-4.
1984: Miranda B; Nieto J; Ruilope L; Alcázar J M; de Villa L F; Rodicio J L
[Usefulness of xipamide alone or associated with a beta blocker in the treatment of idiopathic arterial hypertension]
Medicina clínica 1984;83(16):668-70.
1984: Miranda B; Ruilope L; Mancheño E; Arribas F; García-Robles R; Alcázar J M; Nieto J; Sancho J; Rodicio J L
[Beta-adrenergic blockers and renin-angiotensin-aldosterone system in healthy individuals and patients with arterial hypertension]
Medicina clínica 1984;83(14):572-4.
1984: García-Robles R; Ruilope L; Mancheño E; Hurtado A; Alcázar J M; Varela C; de la Calle H; Rodicio J L; Sancho J
Dopaminergic modulation of aldosterone secretion: effect of sodium balance and postural changes.
Revista española de fisiología 1984;40(1):63-8.
1983: Bello I; Ruilope L M; Pérez Pérez A J; Morales J M; Millet V G; Alcázar J M; Ortega R; Rodicio J L
[Phosphorus and arterial hypertension in idiopathic hypercalciuria]
Medicina clínica 1983;81(16):712-3.
1983: Ruilope L; Garcia-Robles R; Sancho-Rof J; Paya C; Rodicio J L; Strong C G; Knox F G; Romero J C
Effect of furosemide on renal function in the stenotic and contralateral kidneys of patients with renovascular hypertension.
Hypertension 1983;5(6 Pt 3):V43-7.
1983: Garcia-Robles R; Ruilope L; Hurtado A; Rodicio J; Sancho J
Dopaminergic control of prolactin and blood pressure.
Hypertension 1983;5(1):155-6.
1983: Parada J; Ruilope L; García Rohles R; Rodríguez Alvariño J
The 24-hour control of blood pressure in hypertension of chronic renal disease with mepindolol.
Clinical therapeutics 1983;5(5):540-4.
1983: Ruilope L; Millet V G; Alcazar J M; Prieto C; Tresguerres J A; Garcia-Robles R; Sancho J; Rodicio J L
Participation of renal prostaglandins in the nephrotic syndrome.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association 1983;19():738-43.
1983: Morales J M; Colina F; Arteaga J; Barrientos A; Millet V G; Ruilope L M; Alcazar J M; Rodicio J L
Clinical implications of the presence of refractile particles in the liver of haemodialysis patients.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association 1983;19():265-9.
1982: Ruilope L; Garcia Robles R; Barrientos A; Bernis C; Alcazar J; Tresguerres J A; Mancheño E; Millet V G; Sancho J; Rodicio J L
The role of urinary PGE2 and renin-angiotensin-aldosterone system in the pathogenesis of essential hypertension.
Clinical and experimental hypertension. Part A, Theory and practice 1982;4(6):989-1000.
1982: Ruilope L; Garcia Robles P; Bernis C; Barrientos A; Alcazar J; Tresguerres J A; Sancho J; Rodicio J L
Role of renal prostaglandin E2 in chronic renal disease hypertension.
Nephron 1982;32(3):202-6.
1981: Ruilope L; Bernis C; Garcia-Robles R; Alcazar J; Barrientos A; Tresguerres J A; Rodicio J
Urinary prostaglandin E2 in chronic renal disease.
Clinical nephrology 1981;16(4):215.
1981: Jarillo M D; Alcázar J M; Pérez Díaz V; Gutiérrez Millet V; Morales J M; Barrientos A; Rodicio J L; Ruilope L M
[Hypertensive crisis. Clinical and therapeutic study of 130 cases (author's transl)]
Medicina clínica 1981;76(10):427-32.
1981: Alcazar J M; Bello I; Arteaga J; Ruilope L; Barrientos A; Rodicio J L
Sarcoidosis and renal failure.
Nephron 1981;29(5-6):281.
1980: Jarillo M D; Coca M C; Díaz Rubio C; Bello I; Gutiérrez-Millet V; Ruilope L M; Rodicio J L; Alvarez Ude F
[Low dose clofibrate in the treatment of hypertriglyceridemia in hemodialysis patients (author's transl)]
Medicina clínica 1980;75(8):334-7.
1980: Ruilope L; Alcazar J M; Diaz V P; Jarillo M D; Millet V G; Rodicio J L
A fixed combination of hydrochlorothiazide and amiloride for the treatment of essential hypertension.
Clinical therapeutics 1980;3(1):15-20.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Luis Ruilope

Research Profile (preview)

Disorders

Chemicals & Drugs

Concepts & Ideas

Anatomy

Physiology

Procedures

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Luis Ruilope (preview)

All Publications